Growth Hormone Secretagogues (GHS) (28 Offers)
Dragon Pharma GH Secretagogues offer a sophisticated approach to stimulating your body's natural growth hormone production. This category includes research peptides like CJC-1295 and Ipamorelin, designed to support muscle growth, improve recovery, and enhance body composition through targeted hormonal signaling.
Growth Hormone Releasing Peptide (GHRP)
Ipamorelin by British Dragon contains 5 mg of Ipamorelin in a lyophilized powder form, supplied in a 2 mL vial. It is a selective GHRP that stimulates natural GH release without increasing cortisol or prolactin.
Growth Hormone Releasing Peptide (GHRH)
British Dragon Tesamorelin is a lyophilized GHRH analog that stimulates endogenous growth hormone release, commonly used for visceral fat reduction, enhanced recovery, and improved sleep quality in performance-focused protocols.
Drug Class: Growth Hormone Secretagogue Blend (GHRH + GHRP)
Composition:
- CJC 1295 No DAC 5 mg
- Ipamorelin 5 mg
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Subcutaneous Injection
Laboratory Test: View Lab Report
Drug Class: Growth Hormone-Releasing Hormone (GHRH) Analog
Composition: CJC-1295 with Drug Affinity Complex (DAC)
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Injectable Use After Reconstitution
Drug Class: Growth Hormone Releasing Peptide
Composition: GHRP-2 5 mg
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Subcutaneous Injection
Laboratory Test: View Lab Report
Drug Class: Growth Hormone Releasing Peptide
Composition: GHRP-6 10 mg
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Subcutaneous Injection
Laboratory Test: View Lab Report
Drug Class: Growth Hormone Releasing Peptide (GHRP)
Composition: Examorelin (Hexapeptide)
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Growth Hormone Releasing Peptide (GHRP)
Composition: Ipamorelin (Pentapeptide)
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
Laboratory Test: View Lab Report
For Injectable Use After Reconstitution
Drug Class: Growth Hormone Secretagogue Blend
Composition:
- Ipamorelin 5 mg
- Tesamorelin 5 mg
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Subcutaneous Injection
Laboratory Test: View Lab Report
Drug Class: Growth Hormone-Releasing Hormone (GHRH) Analog
Composition: Sermorelin Acetate
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Subcutaneous Injection After Reconstitution
Drug Class: Growth Hormone-Releasing Hormone (GHRH) Analog
Composition: Tesamorelin 5 mg
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Subcutaneous Injection After Reconstitution
Growth Hormone Releasing Peptide
Ipamorelin by Kalpa Pharmaceuticals contains 5 mg of Ipamorelin in a lyophilized powder form, supplied in a 2 mL vial. It is a selective GHRP that stimulates natural GH release without increasing cortisol or prolactin.
Growth Hormone Releasing Hormone
Tesamorelin by Kalpa Pharmaceuticals contains 5 mg of Tesamorelin in a lyophilized powder form, supplied in a 2 mL vial. It is a potent GHRH analog known for reducing visceral abdominal fat and increasing natural GH production.
Drug Class: Growth Hormone Secretagogue Blend (GHRH + GHRP)
Composition:
- CJC-1295 (No DAC) 5 mg
- Ipamorelin 5 mg
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Peptide Hubs
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: Growth Hormone-Releasing Hormone (GHRH) Analog
Composition: Mod GRF 1-29
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Peptide Hubs
Laboratory Test: View Lab Report
For Subcutaneous Injection
Drug Class: Growth Hormone Secretagogue
Composition: GHRP-2
Dosage: 5 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Peptide Hubs
For Research Use Only
Laboratory Test: View Lab Report
Dragon Pharma GH Secretagogues: Researching Natural Growth Hormone Release
Growth Hormone Secretagogues (GHS) represent a advanced class of research peptides designed to stimulate the body's pituitary gland to produce and release its own growth hormone. Dragon Pharma offers a range of these compounds, including CJC-1295, Ipamorelin, and Tesamorelin, each with a unique profile for studying pulsatile GH release. This approach allows researchers to explore the benefits of elevated growth hormone levels, including enhanced recovery and metabolic function, through the body's natural signaling pathways.
How Growth Hormone Secretagogues Work
GHS peptides function by mimicking natural signaling molecules that trigger growth hormone release. They primarily bind to two types of receptors: Growth Hormone Releasing Hormone (GHRH) receptors and Ghrelin receptors. This dual-action approach stimulates the pituitary gland to produce a pulse of GH, resulting in a natural rise in IGF-1 levels. This process is studied for its potential to support anabolic conditions without introducing exogenous hormones into the body.
Key Peptides and Their Research Profiles
The Dragon Pharma GHS catalog includes several well-researched peptides, each with distinct characteristics for various research applications.
- CJC-1295: A GHRH analogue known for its long half-life, supporting sustained elevation of GH levels for prolonged research periods.
- Ipamorelin: A GHRP known for its strong GH-release efficacy with a low potential for stimulating hunger or cortisol release.
- GHRP-2 & GHRP-6 (GHRPs): Potent ghrelin receptor agonists that produce a strong GH pulse, with GHRP-6 also noted for its appetite-stimulating effects.
- Hexarelin: A powerful GHRP known for its potent GH-releasing ability, often researched for its strong, acute effects.
- Tesamorelin: A GHRH analogue specifically studied for its potential to reduce visceral adipose tissue while increasing IGF-1 levels.
Synergistic Stacks and Research Protocols
Many researchers combine GHS peptides to create synergistic effects. A common protocol involves pairing a GHRH analogue like CJC-1295 with a GHRP like Ipamorelin. This combination is studied for its potential to amplify the GH pulse beyond what either compound can achieve alone. Understanding the half-lives and binding affinities of these peptides is crucial for designing effective timing and dosing schedules in research settings.
Considerations for GHS Research
While GHS peptides work through natural pathways, they still represent potent research compounds. Consistent timing of administration is often crucial due to the body's natural pulsatile release of GH. Researchers should also be aware that some GHS peptides can cause a temporary increase in cortisol and prolactin, and may lead to desensitization with prolonged, continuous use. A structured cycling protocol is often implemented in research designs to maintain receptor sensitivity.
